1. Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder
- Author
-
Şeref Şimşek, Abdullah Çim, Savaş Kaya, and İhsan Çetin
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Inflammation ,Gastroenterology ,Tissue plasminogen activator ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,mental disorders ,E-selectin ,medicine ,Patient group ,Genetics (clinical) ,biology ,General Neuroscience ,medicine.disease ,Pathophysiology ,030104 developmental biology ,Autism spectrum disorder ,Immunology ,biology.protein ,Autism ,Neurology (clinical) ,medicine.symptom ,Psychology ,Check List ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Although the etiopathology of autism spectrum disorder (ASD) is not clear, immune dysfunction has been proposed as a mechanism for the pathophysiology of ASD. The purpose of this study is to examine serum levels of tissue plasminogen activator (t-PA) and some adhesion molecules in children with ASD that have not been investigated previously in detail. The study group included 35 male children aged from 2 to 9 diagnosed with ASD according to DSM-V criteria. Soluble platelet endothelial adhesion molecule-1 (sPECAM-1), P-selectin, E-selectin, and t-PA in the serum were determined with enzyme-linked immunosorbent assay. Autism behavior check list (ABC) is used for the assessment of ASD severity. The levels of t-PA (P = 0.025) and E-selectin (P = 0.007) was detected significantly higher in children with ASD than control group. Serum levels of sPECAM-1 showed statistically significant negative correlation with sensory, body and object-use, language, social, and self-help and total scores in the patient group (r = -0.349, P = 0.04; r = -0.411, P = 0.01; r = -0.412, P = 0.01; r = -0.417, P = 0.01, and r = -0.531, P
- Published
- 2016
- Full Text
- View/download PDF